Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...

cAMP-dependent Protein Kinase Pathways

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...

Alzheimer Disease ll: Pathophysiology

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

Caspases

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

HSP90 is involved in curcumin-mediated inhibition of tau aggregation.

Biochemical and biophysical research communications·2026

Same author

Azeliragon attenuates cerebral infarction aggravation in diabetic rats: Receptor for advanced glycation end-product as a novel therapeutic target.

Experimental neurology·2025

Same author

Corrigendum to "Verteporfin is an effective inhibitor of HCMV replication" [Virus Research (2024) 1-5/199475].

Virus research·2025

Same author

Palmitoyl-L-carnitine induces tau phosphorylation and mitochondrial dysfunction in neuronal cells.

PloS one·2024

Same author

Verteporfin is an effective inhibitor of HCMV replication.

Virus research·2024

Same author

Assessing soil pollution concerns in proximity to Fence-type solar photovoltaic system installations.

Heliyon·2024

Search research articles

Related Experiment Video

Updated: May 18, 2026

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase

Published on: June 24, 2025

SUMO1 modulates Aβ generation via BACE1 accumulation.

Sang-Moon Yun¹, Sun-Jung Cho, Jae Chun Song

¹Division of Brain Diseases, Center for Biomedical Sciences, Korea National Institute of Health, Chungcheongbuk-do, Republic of Korea.

Neurobiology of Aging

|September 15, 2012

Summary

Small ubiquitin-like modifier (SUMO)-1 regulates beta-secretase (BACE1) levels, impacting amyloid precursor protein processing and beta-amyloid (Aβ) generation in Alzheimer's disease. SUMO1 is a potential therapeutic target for reducing BACE1 accumulation.

More Related Videos

Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms

Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms

Published on: January 25, 2018

Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System

Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System

Published on: December 28, 2017

Related Experiment Videos

Last Updated: May 18, 2026

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase

Published on: June 24, 2025

Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms

Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms

Published on: January 25, 2018

Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System

Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System

Published on: December 28, 2017

Area of Science:

Neuroscience
Molecular Biology
Biochemistry

Background:

Protein accumulation is key in neurodegenerative diseases like Alzheimer's.
Beta-secretase (BACE1) initiates beta-amyloid (Aβ) generation and is elevated in Alzheimer's brains.
Mechanisms driving BACE1 accumulation remain largely unknown.

Purpose of the Study:

Investigate the mechanisms of BACE1 accumulation in Alzheimer's disease.
Determine the role of small ubiquitin-like modifier (SUMO)-1 in regulating BACE1 levels.
Explore SUMO1 as a potential therapeutic target for Alzheimer's disease.

Main Methods:

Coimmunoprecipitation assays to confirm protein interactions.
Gain and loss of function experiments to assess SUMO1's impact on BACE1.
Analysis of BACE1 and SUMO1 levels in response to Aβ and apoptosis in neuronal cells and transgenic mouse models.

Main Results:

SUMO1 directly interacts with BACE1's dileucine motif, regulating its protein levels.
Altering SUMO isoforms affects BACE1 levels, amyloid precursor protein processing, and Aβ generation.
Aβ increased SUMO1 levels, and SUMO1 overexpression reduced Aβ generation via BACE1 C-terminus fragments.

Conclusions:

SUMO1 is a novel regulator of BACE1 accumulation and Aβ generation.
SUMO1 plays a significant role in Alzheimer's disease pathogenesis.
SUMO1 represents a potential therapeutic target for Alzheimer's disease.